ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2510

Validation of the Modified Stokes Ankylosing Spondylitis Spinal Score (mSASSS) as a Tool to Assess Axial PsA

Daniel Pau1, Justine (Yang) Ye 2, Sevket Tunc 3, Antonio Wong 3, Vinod Chandran 3, Richard Cook 4 and Dafna Gladman 5, 1University of Toronto, Toronto, Canada, 2University Health Network, University of Toronto, Toronto, ON, Canada, 3University Health Network, University of Toronto, Toronto, Canada, 4University of Waterloo, Waterloo, Canada, 5Toronto Western Hospital, Toronto, Canada, Toronto, ON, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: modified stoke ankylosing spondylitis spinal score (MSASSS) and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster III: Psoriatic Arthritis, Clinical Features

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Axial joint involvement commonly links psoriatic arthritis (PsA) to spondyloarthritis with widely variable prevalence (25-70%). Patients with axial PsA (AxPsA) are older than patients with ankylosing spondylitis (AS) and identifying radiographic changes related to the spondylitis may be more challenging leading to disagreement among readers. Currently, there is no universally accepted method to score AxPsA. In AS, the mSASSS system is the most widely used tool to assess the severity of spondylitis and define progression. Based on previous studies in AxPsA, the mSASSS had the highest sensitivity, specificity, and odd ratios of determining disease progression. We aimed to assess the reliability of the mSASSS scoring system between two rheumatologists and various confounders using the PsA Scoring Module for Axial Radiograph Toronto (SMART) tool developed by Biagioni et al.

Methods: A retrospective study was conducted in which radiographs from 2015-2018 in our Psoriatic Arthritis Clinic database were retrieved by an assessor (DIP) via convenience sampling and scored with the SMART tool by two rheumatologists (SET, AW). According to the SMART tool, patients are scored for the presence of osteophytes, degenerative disc disease, osteopenia, and diffuse proliferative skeletal hyperostosis (DISH). We then removed patients who had DISH recorded in our database. Discordant radiographs were adjudicated by a third independent reader (DDG, N = 11). The intra-rater reliability was reported in Intraclass Correlation Coefficient (ICC) with the balanced one-fold random model in all patients as scored by two readers (N = 119), and after adjudication and removing the DISH patients (N = 109).

Results: Patients (N = 119) with well-established PsA with and without axial disease were included. The mean age was 58.19 ± 14.15 years, the mean age at PsA diagnosis was 36.74 ± 12.59 years. 17 patients had inflammatory back pain and 34 had mechanical back pain. The intra-rater ICC between readers of the total mSASSS, cervical mSASSS, and lumbar mSASSS were 0.25, 0.23, and 0.20 respectively. With DISH exclusion, the ICC were 0.89, 0.93, and 0.40 respectively.

Conclusion: Initial results demonstrated poor agreement between readers in the presence of DISH and other confounders. With removal of radiographs with DISH and adjudication of discordant readings, the total mSASSS demonstrated moderate intra-reader reliability. Therefore, the presence of DISH leads to misinterpretation of mSASSS scores and should be considered when reading radiographs in AxPsA.


Disclosure: D. Pau, None; J. Ye, None; S. Tunc, None; A. Wong, None; V. Chandran, None; R. Cook, None; D. Gladman, AbbVie, 2, 5, Amgen, 2, 5, BMS, 5, Celgene, 2, 5, Eli Lilly, 2, 5, Galapagos, 5, Galapagos NV, 5, Gilead, 5, GSI, 5, Janssen, 5, Janssen Research & Development, LLC, 2, Novartis, 2, 5, Pfizer, 2, 5, UCB, 2, 5.

To cite this abstract in AMA style:

Pau D, Ye J, Tunc S, Wong A, Chandran V, Cook R, Gladman D. Validation of the Modified Stokes Ankylosing Spondylitis Spinal Score (mSASSS) as a Tool to Assess Axial PsA [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/validation-of-the-modified-stokes-ankylosing-spondylitis-spinal-score-msasss-as-a-tool-to-assess-axial-psa/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validation-of-the-modified-stokes-ankylosing-spondylitis-spinal-score-msasss-as-a-tool-to-assess-axial-psa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology